newsfilter
← Latest News
GlobeNewswire·

UroGen Pharma to Present at the Guggenheim Securities 3rd Annual Healthcare Innovation Conference

PRINCETON, N.J., Nov. 03, 2026 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ:URGN), a biotechnology company focused on transforming the treatment of urothelial and specialty cancers, today announced that management